In view of this evidence and previous studies showing that GSK3β activation is involved in the mechanisms of HIV neurotoxicity [60], we concluded that targeting the GSK3β pathway with lithium might be of value in the management of the cognitive impairment [76,81–83]. The gene discussed is GSK3B; the disease is Cognitive impairment.